Document is current
Any future updates will be listed below
-
Authors
Martens, Marieke A. G. https://orcid.org/0000-0003-0108-1327
Zghoul, Tarek https://orcid.org/0000-0002-7065-3635
Watson, Evelyn
Rieger, Sebastian W. https://orcid.org/0000-0001-5414-645X
Capitão, Liliana P.
Harmer, Catherine J. https://orcid.org/0000-0002-1609-8335
- License Information
-
More Information
Article History
Received: 20 October 2023
Revised: 14 May 2024
Accepted: 17 May 2024
First Online: 27 May 2024
Competing interests
: CH has received consultancy fees from P1vital Ltd., Janssen Pharmaceuticals, Sage Therapeutics, Pfizer, Zogenix, Compass Pathways, and Lundbeck. CH holds grant income from Zogenix, UCB Pharma, Janssen Pharmaceuticals. The remaining authors declare no competing interests.
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
